icon-folder.gif   Conference Reports for NATAP  
 
  HEPDART 2013: Frontiers in Drug Development for Viral Hepatitis
December 8-12, 2013
Big Island, Hawaii
Back grey_arrow_rt.gif
 
 
 
No Pharmacokinetic Interaction Between the Hepatitis C Virus Non-Structural Protein 5A Inhibitor MK-8742 and Ethinyl Estradiol and Levonorgestrel
 
 
  Reported by Jules Levin
HEP DART Dec 8-12 2013
Biennial Frontiers in Drug Development for Viral Hepatitis
The Big Island, Hawaii
 
WL Marshall1, WW Yeh1, L Caro1, S Langley1, J Ma1, E Mangin1, X Huang1, R Valesky1, TE O'Reilly2, and JR Butterton1 1Merck, Whitehouse Station NJ, USA; 2Celerion, Phoenix, AZ, USA

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif